(肺癌) Avelumab新藥資訊


這次跟各位介紹的是,非小細胞肺癌的第三階段臨床試驗, 實驗名稱為 Avelumab in Non-small cell lung cancer,這個也有在台灣進行,日本韓國等地都有。試驗藥品為Avelumab(p-INN),實驗概要請參考下面英文。

To demonstrate superiority with regard to overall survival of avelumab versus docetaxel in subjects with programmed death ligand 1 (PD-L1) positive, non-small cell lung cancer (NSCLC) after failure of a platinum-based doublet.

你沒看錯,亮點在pd-l1。該實驗的參加方法以及招募對象等請參考下面連結

https://clinicaltrials.gov/ct2/show/study/NCT02395172?

#肺癌

Copyright© 2015 新義豊株式会社 All rights reserved.